A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer (Q53027312)
scientific article published on January 1, 1992
Language:
Current Data About A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer
(P31) (Q13442814)
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P304) 165-171
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P407) (Q1860)
(P248)
(P698) 1553366
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1553366
(P813) Saturday, October 8, 2022

(P433) 2
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P478) 7
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P577) Wednesday, January 1, 1992
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P921) (Q60315441)
(P887)

(Q212961)
(P887)

(P1433) (Q15762014)
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

(P1476) "A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer" (language: en)
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

(P2093) DuBrow R
(P1545) 5
(P248)
(P698) 1553366
(P813) Thursday, May 10, 2018
(P854) http://europepmc.org/abstract/MED/1553366

J. L. Abbruzzese
(P1545) 1
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

C. F. Gholson
(P1545) 2
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

K. Daugherty
(P1545) 3
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

E. Larson
(P1545) 4
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

R. DuBrow
(P1545) 5
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

R. Berlin
(P1545) 6
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

B. Levin
(P1545) 7
(P248)
(P698) 1553366
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1553366
(P813) Saturday, October 8, 2022

other details
description scientific article published on January 1, 1992

External Links
(P356) 10.1097/00006676-199203000-00006
(P698) 1553366